Long-term outcomes are good in the majority of young children with refractory febrile status epilepticus (SE), according to new research presented at AES 2018.
Specialists from the University of Texas Southwestern Medical Center, in Dallas, Texas, USA, performed a single-center retrospective observational study, identifying all patients aged between 1 month and 5 years who were admitted to the pediatric ICU with refractory febrile SE in the period 2008-2017.
The condition was defined as SE where the only acute provocation was fever, which persisted despite the administration of at least two parenteral antiepileptic medications, including a benzodiazepine.